» FDA Clears The Pathwork(R) Tissue Of Origin Test For Hard-To-Identify Tumors
Pathwork Diagnostics, Inc., a molecular diagnostics company focused on oncology, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Pathwork® Tissue of Origin Test for…